ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo
Personal Information
Organization / Workplace
Greater Philadelphia Area United States
Occupation
co-Program Leader in Molecular Therapeutics
Industry
Medical / Health Care / Pharmaceuticals
About
Wafik El-Deiry, MD, PhD, FACP, an American Cancer Society Professor, is Deputy Director & Program Leader at Fox Chase Cancer Center. Until Sept '14 he was the Rose Dunlap Professor of Medicine & Chief of Hematology/Oncology, Assoc Director for Translational Research at Penn State Univ. Cancer Inst. He earned MD & PhD degrees at Univ of Miami & completed medicine residency at Johns Hopkins Hospital & oncology fellowship at Johns Hopkins Oncology Center. He discovered p21(WAF1) as a p53 target gene that explained the mammalian stress response. This is the most highly cited original work published in Cell. Dr. El-Deiry joined the Univ of Pennsylvania as Assistant Professor of Medicine & G...
Contact Details

Presentations(12)Ìý

See all
ASCO heterogeneity presentation El-Deiry 6-4-17
ASCO heterogeneity presentation El-Deiry 6-4-17ASCO heterogeneity presentation El-Deiry 6-4-17
ASCO heterogeneity presentation El-Deiry 6-4-17
Ìý
MKSAP 17 CME credits 8-24-16
MKSAP 17 CME credits 8-24-16MKSAP 17 CME credits 8-24-16
MKSAP 17 CME credits 8-24-16
Ìý
Triumph El-Deiry July 2011
Triumph El-Deiry July 2011Triumph El-Deiry July 2011
Triumph El-Deiry July 2011
Ìý

Documents(5)Ìý

See all
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelphia, PA
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelphia, PAPaving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelphia, PA
Paving the Way for Personalized Therapy | Fox Chase Cancer Center - Philadelphia, PA
Ìý
Targeted translational RFA for Rare tumor subtypes and exceptional responders-Revised
Targeted translational RFA for Rare tumor subtypes and exceptional responders-RevisedTargeted translational RFA for Rare tumor subtypes and exceptional responders-Revised
Targeted translational RFA for Rare tumor subtypes and exceptional responders-Revised
Ìý
Translational Medicine Poster 8-12-15 revised agenda
Translational Medicine Poster 8-12-15 revised agendaTranslational Medicine Poster 8-12-15 revised agenda
Translational Medicine Poster 8-12-15 revised agenda
Ìý